5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
India
The Biopreservation Market is Segmented by Product (Biopreservation Media and Equipment), Application Area (Biobanking, Regenerative Medicine, Drug Discovery, and Other Application Areas), End User (Biobanks, Hospitals, and Other End Users), and Geography (North America, Europe, Asia Pacific, Middle-East and Africa, and South America).
Study Period:
2018 - 2026
Base Year:
2020
Fastest Growing Market:
Asia Pacific
Largest Market:
North America
CAGR:
15.3 %
Biopreservation is a process that helps store biological samples for a longer period. Cells, tissues, and plasmas are some of the common biological samples preserved through biopreservation.
By Products | |||||
Biopreservation Media | |||||
|
By Application Area | |
Biobanking | |
Regenerative Medicine | |
Drug Discovery | |
Other Application Areas |
By End User | |
Biobanks | |
Hospitals | |
Other End Users |
By Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Report scope can be customized per your requirements. Click here.
Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early-stage of stem cell culture depends on a continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects.
Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of the liver, lungs, pancreas, heart, and kidney.
To understand key trends, Download Sample Report
The North American market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues (like peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives), across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in this region, which is supporting the sharing of biological samples.
To understand geography trends, Download Sample Report.
The biopreservation market is highly competitive and consists of several major players. Companies, like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International, hold a substantial market share in the market studied.
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Improving Healthcare Expenditure
4.2.2 Adoption of In-house Sample Storage in Hospitals and Labs
4.2.3 Increasing R&D Investment
4.3 Market Restraints
4.3.1 High Cost of the Instruments and its Maintenance
4.3.2 Possibility of Tissue Injury During Preservation and Thawing
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Products
5.1.1 Biopreservation Media
5.1.2 Equipment
5.1.2.1 Temperature Maintaining Units
5.1.2.2 Consumables
5.1.2.3 Other Equipment
5.2 By Application Area
5.2.1 Biobanking
5.2.2 Regenerative Medicine
5.2.3 Drug Discovery
5.2.4 Other Application Areas
5.3 By End User
5.3.1 Biobanks
5.3.2 Hospitals
5.3.3 Other End Users
5.4 By Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioCision LLC
6.1.2 BioLife Solutions Inc.
6.1.3 Cesca Therapeutics Inc.
6.1.4 Core Dynamics Ltd
6.1.5 Custom Biogenic Systems Inc.
6.1.6 Lifeline Scientific Inc.
6.1.7 Merck KGaA
6.1.8 Princeton CryoTech Inc.
6.1.9 VWR International
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments